ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Micko22
|
484 |
151K |
10 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
484
|
151K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Micko22
|
484 |
151K |
10 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
484
|
151K
|
10
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
239
|
60K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
1 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
239
|
60K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
1 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
239
|
60K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
1 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
239
|
60K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Micko22
|
255 |
96K |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
255
|
96K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
Micko22
|
24 |
9.3K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
9.3K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
Micko22
|
24 |
9.3K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
9.3K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
Micko22
|
24 |
9.3K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
9.3K
|
6
|
|
ASX - By Stock
|
GSR |
Re:
Ann: Receipt of Shareholder Voting Intention Statements
|
|
Micko22
|
17 |
5.3K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
17
|
5.3K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
239
|
60K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
239
|
60K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
239
|
60K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
239 |
60K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
239
|
60K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First patient treated with OncoSil device in Turkiye
|
|
Micko22
|
8 |
2.7K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
8
|
2.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
Micko22
|
26 |
6.6K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
26
|
6.6K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
Micko22
|
26 |
6.6K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
Micko22
|
26 |
6.6K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
10K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
40
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
10K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
40
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
10K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
10K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
10K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
Micko22
|
118 |
33K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
118
|
33K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
Micko22
|
118 |
33K |
0 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
118
|
33K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
Micko22
|
118 |
33K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
118
|
33K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
SOFDRA market size
|
|
Micko22
|
62 |
27K |
11 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
62
|
27K
|
11
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
14K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
5 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
13K |
4.6M |
3 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
13K
|
4.6M
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
Micko22
|
55 |
22K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
55
|
22K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.9K |
3.3M |
19 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
19
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Micko22
|
39 |
11K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
39
|
11K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Micko22
|
39 |
11K |
1 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
39
|
11K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Micko22
|
39 |
11K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
11K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Micko22
|
14 |
3.6K |
11 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
14
|
3.6K
|
11
|
|